Anti-Nivolumab Non-Neutralizing Antibody (SAA2349) (AS870043)

Datasheet Share product Copy info

Price(USD): $

Spec:

20ug
50ug
100ug

Number:

Overview
Images
References
Datasheet

Overview

Catalog No.

AS870043

Description

Anti-Nivolumab Non-Neutralizing Antibody (SAA2349) [SAA2349] (AS870043) is a rabbit monoclonal antibody detecting Nivolumab in ELISA.

Highlights

●Rabbit Monoclonal — High specificity, affinity, and excellent lot-to-lot consistency.

Applications

ELISA

Host species

Rabbit

Isotype

IgG

Clone ID

SAA2349

Clonality

Monoclonal

Immunogen

Nivolumab

Tested applications

ELISA

Target

Nivolumab, BMS-936558, MDX-1106, MDX1106, MDX 1106, ONO-4538, OPDIVO

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Form

Liquid

Storage buffer

0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information

Application	Dilution
ELISA	1:2000-1:20000

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Note

For research use only

Images

Bioactivity

Detects research grade Nivolumab (Catalog No: HS870096) in indirect ELISA

References

Datasheet

Anti-Nivolumab Non-Neutralizing Antibody (SAA2349).pdf

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

Recombinant Proteins

Antibodies

Assay Kits

Anti-Nivolumab Non-Neutralizing Antibody (SAA2349) (AS870043)

Overview

Images

References

Datasheet

Quick access

Contact Us